SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001600132-18-000038
Filing Date
2018-03-26
Accepted
2018-03-26 16:48:36
Documents
4
Period of Report
2018-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A blphproxymarch2018.htm PRE 14A 543669
2 blphlogoa28.jpg GRAPHIC 32979
3 blphproxycarda05.jpg GRAPHIC 151853
4 poxynotice.jpg GRAPHIC 124211
  Complete submission text file 0001600132-18-000038.txt   959897
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36845 | Film No.: 18713282
SIC: 2834 Pharmaceutical Preparations